NEW Enterprise Associates 13 L.P., 10% Owner at Epizyme, Inc. (EPZM), bought 406,500 shares at $19.31 ($8.0M) on 2013-11-15, disclosed to the SEC on 2013-11-18.
Open-market purchase of $8.0M EPZM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.04 | 163,620 | $3.1M | 39.0% |
| 2 | $19.99 | 152,459 | $3.0M | 38.1% |
| 3 | $20.91 | 40,921 | $856K | 10.7% |
| 4 | $19.31 | 25,800 | $498K | 6.2% |
| 5 | $20.31 | 23,700 | $481K | 6.0% |
| Total | $19.68 avg | 406,500 |
| $8.0M |
| 100% |
| Filing → |
| TSRO | BUY | 2018-03-06 | $6.7M | — | Filing → |
| RARX | BUY | 2016-10-31 | $4.4M | — | Filing → |
| RARX | SELL | 2016-10-31 | $6K | — | Filing → |